Globus Medical Sees 9.1% EPS Growth, $3.2B Revenue with Estimate Up Six Cents
Globus Medical carries a Zacks Rank #1 Strong Buy with a current-year earnings consensus of $4.34 per share, up 9.1%, and expected revenues of $3.2 billion, an 8% increase. Its earnings estimate rose by six cents over the past week, reflecting upward analyst revisions.
1. Zacks Rank and Analyst Sentiment
Globus Medical holds a Zacks Rank #1 Strong Buy designation, reflecting broad analyst confidence and placing it among the top-rated names in the medical device sector.
2. Earnings and Revenue Projections
Analysts forecast 2026 earnings of $4.34 per share, a 9.1% increase from the prior year, alongside revenues of $3.2 billion, up 8% year-over-year.
3. Recent Estimate Revision
The consensus EPS estimate for Globus Medical climbed by six cents over the past seven days, signaling positive momentum in analyst outlooks on the company’s profitability.